BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 175 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $14,943,000 | +260.9% | 226,782 | +486.7% | 0.35% | +328.0% |
Q4 2021 | $4,140,000 | -75.6% | 38,654 | -76.6% | 0.08% | -68.3% |
Q3 2021 | $16,971,000 | -0.6% | 165,069 | -15.0% | 0.26% | +7.0% |
Q2 2021 | $17,080,000 | +50.3% | 194,183 | +66.1% | 0.24% | +69.2% |
Q1 2021 | $11,367,000 | -50.7% | 116,911 | -43.1% | 0.14% | -43.5% |
Q4 2020 | $23,042,000 | +107.7% | 205,454 | +71.7% | 0.25% | +19.3% |
Q3 2020 | $11,092,000 | +468.8% | 119,652 | +378.6% | 0.21% | +307.7% |
Q2 2020 | $1,950,000 | -26.1% | 25,000 | -28.6% | 0.05% | +8.3% |
Q4 2017 | $2,639,000 | – | 35,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,278,459 | $60,015,000 | 10.23% |
Casdin Capital, LLC | 412,500 | $10,865,000 | 9.60% |
Boxer Capital, LLC | 313,626 | $8,261,000 | 7.13% |
Opaleye Management Inc. | 275,000 | $7,244,000 | 3.03% |
RA Capital Management | 878,348 | $23,136,000 | 2.29% |
PFM Health Sciences, LP | 1,008,232 | $26,557,000 | 0.81% |
Perceptive Advisors | 404,404 | $10,652,000 | 0.79% |
Partner Investment Management, L.P. | 18,052 | $475,000 | 0.78% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 680,160 | $17,915,000 | 0.60% |
Redmile Group, LLC | 276,687 | $7,288,000 | 0.54% |